David Annis

Chief Tech/Sci/R&D Officer bei AILERON THERAPEUTICS, INC.

Vermögen: 2 500 $ am 31.03.2024

51 Jahre

Health Technology

Consumer Services

Aktive Positionen von David Annis

Unternehmen	Position	Beginn	Ende
AILERON THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	05.11.2018	-
AILERON THERAPEUTICS, INC.	Corporate Officer/Principal	20.01.2010	-

Unternehmen	Position	Beginn	Ende
NeoGenesis Pharmaceuticals, Inc. NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA	Corporate Officer/Principal	20.01.2010	-
Schering-Plough Research Institute Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.	Corporate Officer/Principal	20.01.2010	-

Harvard University	Doctorate Degree
Georgia Institute of Technology	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Undergraduate Degree	1

Sektoral

Health Technology	4
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
AILERON THERAPEUTICS, INC.	Health Technology

Private Unternehmen	2
NeoGenesis Pharmaceuticals, Inc. NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA	Health Technology
Schering-Plough Research Institute Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.	Health Technology